HAC5306A Nicotine Replacement Therapy Framework
key details
| Value | £6,000,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | London |
| Deadline | 4 Feb 2019 |
| Contract start | 1 Apr 2019 |
| Contract end | 31 Mar 2023 |
| Procedure | open |
| SME suitable | No |
| OCID | ocds-b5fd17-8a3c04ac-c0b9-4aff-8725-231bb7018e64 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Sigma Pharmaceuticals plc | £6,000,000 | 3 Jul 2019 | active |
description
Internal Contract Reference: HAC5306A - Nicotine Replacement Therapies
Contract Title: Nicotine Replacement Therapy Framework
Expressions of Interest start date: 24 December 2018
Tender submissions deadline: 4 February 2019
Initial Contract Duration: 24 months
Extensions: 12 months + 12 months
Estimated Contract Value (including extensions): £3m - £6m
Description: The purpose of this tender is to set up a non-exclusive flexible local framework with a suitable supplier for the provision of Nicotine Replacement Therapy (NRT) products to commissioned Smoking Cessation services in Tower Hamlets and other London Boroughs signed up to the NRT Framework.
The framework will be available for use by all London Borough Councils as listed in the contract documents.
The Council is responsible for paying for Nicotine Replacement Therapy (NRT) such as patches, gums and sprays, which are provided as part of smoking cessation services to our residents. NRT greatly increases the probability that a resident will successful quit smoking and is recommended by NICE.
The cost of suppling NRT is currently re-charged to the Council at the prevailing NHS Digital list price, however following a Market Engagement Event with suppliers of NRT it has been identified that savings could be made by procuring a framework for the supply of NRT by a single contractor. An NRT framework operating across a number of Councils is expected to reduce the cost of NRT products and so make efficiency savings.
Please note that the Council intends to conduct a reverse auction pricing event as part of this tender process. We will be using Prosolis Ltd ("EASiBuy") for the reverse auction event. Tenderers who will participate in the reverse auction are required to sign Supplier Agreement Terms & Conditions A Bidders Workshop will be held on Tuesday 15th January 2019 and all interested suppliers are encouraged to attend. Please contact Mutiur.Rahman@towerhamlets.gov.uk for further details and to book a place.
documents
- https://www.contractsfinder.service.gov.uk/Notice/a4a6fe77-ea52-49b2-8ddd-fe2d4d41ab1a , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 4 Jul 2019 | Award (award) | · | 4a977948-9c60-464c-b0ac-38e4cc24e395-299472 |
more from Tower Hamlets
- CO6101A Liquid Fuel (HVO and Diesel) · £2,900,000 · 2 Jul 2026
- HAR6152: Mobility Aids - Lifts · £740,000 · 2 Jul 2026
- CO6110 Bulk Purchase of Inflatables for the Leisure Centre Estate · £78,000 · 2 Jul 2026
- R6144 Debt Assist · £850,000 · 8 Jun 2026
- P5644 FC034 Albert Jacob House Demolition · 27 Apr 2026
- R6140 Cyber Security Managed SIEM · 27 Apr 2026
- R6112 Microsoft Enterprise Agreement · 27 Apr 2026
- R6138 Laptop Sourcing · £1,381,541 · 4 Feb 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
- LW158 IMP Support (FAME) · Liverpool School of Tropical Medicine · £0
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.